Vulnerable blood in high risk vascular patients: Study design and methods

Contemporary Clinical Trials

Volumn 38, Issue 1, 2014, Pages 121-129

  McDermott, Mary M ^a   Greenland, Philip ^a   Liu, Kiang ^a   Tian, Lu ^b   Green, David ^a   Shah, Sanjiv J ^a   Huffman, Mark ^a   Wilkins, John ^a   Kibbe, Melina ^a,c   Liao, Yihua ^a   Huang, Chiang Ching ^a   Skelly, Christopher ^d   Jacobs, Chad ^e   McCarthy, Walter ^e   Auerbach, Amanda ^a   Lloyd Jones, Donald ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b STANFORD UNIVERSITY   (United States)

^c Jesse Brown Veterans Affairs Hospital   (United States)

^d UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

^e RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Biomarkers; C reactive protein; Coronary events; Intermittent claudication

Indexed keywords

ANTITHROMBOCYTIC AGENT; C REACTIVE PROTEIN; D DIMER; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; SERUM AMYLOID A; AUTACOID; BIOLOGICAL MARKER;

ACUTE DISEASE; AGED; ANTICOAGULANT THERAPY; ARTICLE; BLOOD ANALYSIS; BLOOD SAMPLING; CONTROLLED STUDY; ELECTROCARDIOGRAPHY; FEMALE; HEALTH SERVICE; HEART ARREST; HEART DEATH; HIGH RISK PATIENT; HOSPITALIZATION; HUMAN; ISCHEMIC HEART DISEASE; LEG DISEASE; MAJOR CLINICAL STUDY; MALE; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PROSPECTIVE STUDY; SILENT MYOCARDIAL INFARCTION; STUDY DESIGN; UNSTABLE ANGINA PECTORIS; BLOOD; CASE CONTROL STUDY; HEART MUSCLE ISCHEMIA; LOWER LIMB; METHODOLOGY; PATHOPHYSIOLOGY; RISK FACTOR; THROMBOSIS;

BIOMARKERS; CASE-CONTROL STUDIES; HUMANS; INFLAMMATION MEDIATORS; LOWER EXTREMITY; MYOCARDIAL ISCHEMIA; PERIPHERAL ARTERIAL DISEASE; RESEARCH DESIGN; RISK FACTORS; THROMBOSIS;

EID: 84899867109     PISSN: 15517144     EISSN: 15592030     Source Type: Journal    
DOI: 10.1016/j.cct.2014.03.009     Document Type: Article

References (32)

1. Allison M.A., Ho E., Denenberg J.O., Langer R.D., Newman A.B., Fabsitz R.R., et al. Ethnic-specific prevalence of peripheral arterial disease in the United States. Am J Prev Med 2007, 32:328-333.
2. Fowkes F.G.R., Rudan D., Rudan I., Aboyans V., Denenberg J.O., McDermott M.M., et al. Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis. Lancet 2013, 382(9001):1329-1340.
3. Fowkes F.G., Murray G.D., Butcher I., Heald C.L., Lee R.J., et al. Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality. JAMA 2008, 300:197-208. Ankle Brachial Index Collaboration, [PMID].
4. Go A.S., Mozaffarian D., Roger V.L., Benjamin E.J., Berry J.D., Borden W.B., et al. Executive summary: heart disease and stroke statistics-2013 update: a report from the American Heart Association. Circulation Jan 1 2013, 127(1):143-152.
5. Naghavi M., Libby P., Falk E., Casscells S.W., Litovsky S., Rumberger J., et al. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: part I. Circulation 2003, 108:1664-1672.
6. Falk E., Shah P.K., Fuster V. Pathogenesis of plaque disruption. Atherosclerosis and coronary artery disease 1996, vol. 1:491-507. Lippincott-Raven, Philadelphia.
7. Ross R., Fuster V. The pathogenesis of atherosclerosis. Atherosclerosis and coronary artery disease 1996, vol. 1:441-474. Lippincott-Raven, Philadelphia.
8. Burke A.P., Farb A., Malcom G.T., Liang Y.H., Smialek J., Virmani R. Coronary risk factors and plaque morphology in men with coronary disease who died suddenly. N Engl J Med 1997, 336:1276-1282.
9. Mann J., Davies M.J. Mechanisms of progression in native coronary artery disease: role of healed plaque disruption. Heart 1999, 82:265-268.
10. Ambrose J.A., Tannenbaum M.A., Alexopoulos D., Hjemdahl-Monsen C.E., Leavy J., Weiss M., et al. Angiographic progression of coronary artery disease and the development of myocardial infarction. J Am Coll Cardiol 1988, 12:56-62.
11. Rioufol G., Finet G., Ginon I., Andre-Fouet X., Rossi R., Vialle E., et al. Multiple atherosclerotic plaque rupture in acute coronary syndrome: a three-vessel intravascular ultrasound study. Circulation 2002, 106:804-808.
12. Moss A., Goldstein R.E., Marder V.J., Sparks C.E., Oakes D., Greenberg H., et al. Thrombogenic factors and recurrent coronary events. Circulation 1999, 99:2517-2522.
13. Libby P. Current concepts of the pathogenesis of the acute coronary syndromes. Circulation 2001, 104:365-372.
14. Libby P., Ridker P.M., Maseri A. Inflammation and atherosclerosis. Circulation 2002, 105:1135-1143.
15. McDermott M.M., Guralnik J., Corsi A., Albay M., Macchi C., Bandinelli S., et al. Patterns of inflammation associated with peripheral arterial disease: the InCHIANTI Study. Am Heart J 2005, 150:276-281.
16. McDermott M.M., Green D., Greenland P., Liu K., Criqui M., Chan C., et al. Relation of levels of hemostatic factors and inflammatory markers to the ankle brachial index. Am J Cardiol 2003, 92:194-199.
17. Guralnik J.M., Fried L.P., Simonsick E.M., Kasper J.D., Lafferty M.E. The Women's Health and Aging Study: health and social characteristics of older women with disability 1995, National Institute on Aging, Bethesda, MD, [NIH publication No. 95-4009, Appendix E].
18. McDermott M.M., Greenland P., Liu K., Guralnik J.M., Celic L., Criqui M.H., et al. The ankle brachial index is associated with leg function and physical activity: the Walking and Leg Circulation Study. Ann Intern Med 2002, 136:873-883.
19. McDermott M.M., Criqui M.H., Liu K., Guralnik J.M., Greenland P., Martin G.J., et al. Lower ankle/brachial index, as calculated by averaging the dorsalis pedis and posterior tibial arterial pressures, and association with leg functioning in peripheral arterial disease. J Vasc Surg 2000, 32:1164-1171.
20. Medalie J.H., Goldbourt U. Unrecognized myocardial infarction five-year incidence, mortality, and risk factors. Ann Intern Med 1976, 84:526-531.
21. Yano K., MacLean C.J. The incidence and prognosis of unrecognized myocardial infarction in the Honolulu Heart Program. Arch Intern Med 1989, 149:1528-1532.
22. White A.D., Folsom A.R., Chambless L.E., Sharret A.R., Yang K., Conwill D., et al. Community surveillance of coronary heart disease in the Atherosclerosis Risk in Communities (ARIC) Study: methods and initial two years' experience. J Clin Epidemiol 1996, 49:223-233.
23. Bild D.E., Bluemke D.A., Burke G.L., Detrano R., Diez Roux A.V., Folsom A.R., et al. Multi-ethnic study of atherosclerosis: objectives and design. Am J Epidemiol 2002, 156:871-881.
24. Sheifer S.E., Gersh B.J., Yanez N.D., Ades P.A., Burke G.L., Manolio T.A. Prevalence, predisposing factors, and prognosis of clinically unrecognized myocardial infarction in the elderly (the CHS Study). J Am Coll Cardiol 2000, 35:119-126.
25. Vidula H., Tian L., Criqui M.H., Ferrucci L., Pearce W.H., Greenland P., et al. Biomarkers of inflammation and thrombosis as predictors of near-term mortality in patients with peripheral arterial disease: a cohort study. Ann Intern Med 2008, 148(2):85-93.
26. de Torbal A., Boersma E., Kors J.A., van Herpen G., Deckers J.W., van der Kuip D.A., et al. Incidence of recognized and unrecognized myocardial infarction in men and women aged 55 and older: the Rotterdam Study. Eur Heart J 2006, 27:729-736.
27. Aguilar D., Goldhaber S.Z., Gans D.J., Levey A.S., Porush J.G., Lewis J.B., et al. Clinically unrecognized Q-wave myocardial infarction in patients with diabetes mellitus, systemic hypertension, and nephropathy. Am J Cardiol 2004, 94:337-339.
28. Fowkes F.G., Murray G.D., Butcher I., Heald C.L., Lee R.J., et al. Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis. JAMA Jul 9 2008, 300(2):197-208. Ankle Brachial Index Collaboration.
29. Criqui M.H., Langer R.D., Fronek A., Feigelson H.S., Klauber M.R., McCann T.J., et al. Mortality over a period of 10years in patients with peripheral arterial disease. N Engl J Med 1992, 326(6):381-386.
30. Cushman M., Lemaitre R.N., Kuller L.H., Psaty B.M., Macy E.M., Sharrett A.R., et al. Fibrinolytic activation markers predict myocardial infarction in the elderly: the Cardiovascular Health Study. Arterioscler Thromb Vasc Biol 1999, 19:493-498.
31. Tracy R., Lemaitre Rozenn N., Psaty B.M., Ives D.G., Evans R.W., Cushman M., et al. Relationship of C-reactive protein to risk of cardiovascular disease in the elderly. Arterioscler Thromb Vasc Biol 1997, 17:1121-1127.
32. Pirro M., Bergeron J., Dagenais G.R., Bernard P.-M., Cantin B., Despres J.-P., et al. Age and duration of follow-up as modulators of the risk for ischemic heart disease associated with high plasma C-reactive protein levels in men. Arch Intern Med 2001, 161:2474-2480.